A comparison of studies in which nanoparticles were prepared to target inflammatory cells or mediators, with the aim of enhancing nanoparticle accumulation in inflamed intestinal tissue to improve the treatment of inflammatory bowel disease (IBD) - Comparison - ORKG | ORKG
Comparison
6 contributions
A comparison of studies in which nanoparticles were prepared to target inflammatory cells or mediators, with the aim of enhancing nanoparticle accumulation in inflamed intestinal tissue to improve the treatment of inflammatory bowel disease (IBD)
A table summarizing key aspects of the comparison between different studies that prepared nanoparticles targeting inflammatory cells or mediators to improve the treatment of inflammatory bowel disease (IBD), including the properties of the nanoparticles and their effects in vitro and in vivo.
ORKG Comparisons have changed. We have added new features and improved the user interface. Comparisons might look slightly different, but the comparison data itself remains unchanged.
O. Hartwig, M.A. Shetab Boushehri, K.S. Shalaby et al., Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD, Advanced Drug Delivery Reviews, https://doi.org/10.1016/j.addr.2021.113828